DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Agache I, Beltran J, Akdis C. et al
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma.
Allergy 2020; 1-20
DOI: https://doi.org/10.1111/all.14221.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.